Development of a multi-component gastroretentive expandable drug delivery system (GREDDS) for personalized administration of metformin

References

• Lopes CM, Bettencourt C, Rossi A, et al. Overview on gastroretentive drug delivery systems for improving drug bioavailability. Int J Pharm. 2016;510(1):144–158. doi: 10.1016/j.ijpharm.2016.05.016
   PubMedGoogle Scholar
• Kumar M, Kaushik D. An overview on various approaches and recent patents on gastroretentive drug delivery systems. Recent Pat Drug Deliv Formul. 2018;12(2):84–92. doi: 10.2174/1872211312666180308150218
   PubMedGoogle Scholar
• Pinto JF. Site-specific drug delivery systems within the gastro-intestinal tract: from the mouth to the colon. Int J Pharm. 2010;395(1–2):44–52. doi: 10.1016/j.ijpharm.2010.05.003
   PubMed Web of Science ®Google Scholar
• Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery systems. Expert Opin Drug Deliv. 2006;3(2):217–233. doi: 10.1517/17425247.3.2.217
   PubMedGoogle Scholar
• Baride KS, Chemate SZ, Borkar GS, et al. An overview of the gastroretentive drug delivery system. Int J Pharm Sci Rev Res. 2023;80(2):104–115. doi: 10.47583/ijpsrr.2023.v80i02.016
   Google Scholar
• Uboldi M, Melocchi A, Moutaharrik S, et al. Administration strategies and smart devices for drug release in specific sites of the upper GI tract. J Control Release. 2022;348:537–552. doi: 10.1016/j.jconrel.2022.06.005
   PubMed Web of Science ®Google Scholar
• Awasthi R, Kulkarni GT. Decades of research in drug targeting to the upper gastrointestinal tract using gastroretention technologies: where do we stand? Drug Deliv. 2016;23(2):378–394. doi: 10.3109/10717544.2014.936535
   PubMed Web of Science ®Google Scholar
• Dhiman S, Philip N, Singh TG, et al. An insight on novel approaches & perspectives for gastro-retentive drug delivery systems. Current Drug Deliv. 2023;20(6):708–729. doi: 10.2174/1567201819666220819200236
   PubMed Web of Science ®Google Scholar
• Melocchi A, Uboldi M, Cerea M, et al. A graphical review on the escalation of fused deposition modeling (FDM) 3D printing in the pharmaceutical field. J Pharm Sci. 2020;109(10):2943–2957. doi: 10.1016/j.xphs.2020.07.011
   PubMed Web of Science ®Google Scholar
• Tripathi J, Thapa P, Maharjan R, et al. Current state and future perspectives on gastroretentive drug delivery systems. Pharmaceutics. 2019;11(4):193. doi: 10.3390/pharmaceutics11040193
   PubMed Web of Science ®Google Scholar
• Vrettos NN, Roberts CJ, Zhu Z. Gastroretentive technologies in tandem with controlled-release strategies: a potent answer to oral drug bioavailability and patient compliance implications. Pharmaceutics. 2021;13(10):1591. doi: 10.3390/pharmaceutics13101591
   PubMed Web of Science ®Google Scholar
• Pal R, Pandey P, Nogai L, et al. The future perspectives and novel approach on gastro retentive drug delivery system (GRDDS) with currrent state. J Popul Ther Clin Pharmacol. 2023;30(17):594–613. doi: 10.53555/jptcp.v30i17.2852
   Google Scholar
• Sambre TK, Mehta T, Sambre TT. Saga of gastroretentive drug delivery system: emerging concepts, recent advances and technological progress. Int J Pharm Sci Res. 2023;14(5):2030–2059.
   Google Scholar
• Abramson A, Caffarel-Salvador E, Khang M, et al. An ingestible self-orienting system for oral delivery of macromolecules. Science. 2019;363(6427):611–615. doi: 10.1126/science.aau2277
   PubMed Web of Science ®Google Scholar
• Abramson A, Frederiksen MR, Vegge A, et al. Oral delivery of systemic monoclonal antibodies, peptides and small molecules using gastric auto-injectors. Nat Biotechnol. 2021;40(1):103–109. doi: 10.1038/s41587-021-01024-0
   PubMed Web of Science ®Google Scholar
• Abramson A, Kirtane AR, Shi Y, et al. Oral mRNA delivery using capsule-mediated gastrointestinal tissue injections. Matter. 2022;5(3):975–987. doi: 10.1016/j.matt.2021.12.022
   Google Scholar
• Altreuter DH, Kirtane AR, Grant T, et al. Changing the pill: developments toward the promise of an ultra-long-acting gastroretentive dosage form. Expert Opin Drug Deliv. 2018;15(12):1189–1198. doi: 10.1080/17425247.2018.1544615
   PubMed Web of Science ®Google Scholar
• Byrne J, Huang HW, McRae JC, et al. Devices for drug delivery in the gastrointestinal tract: a review of systems physically interacting with the mucosa for enhanced delivery. Adv Drug Deliv Rev. 2021;177:113926. doi: 10.1016/j.addr.2021.113926
   PubMed Web of Science ®Google Scholar
• Caffarel-Salvador E, Abramson A, Langer R, et al. Oral delivery of biologics using drug-device combinations. Curr Opin Pharmacol. 2017;36:8–13. doi: 10.1016/j.coph.2017.07.003
   PubMed Web of Science ®Google Scholar
• Chu JN, Traverso G. Foundations of gastrointestinal-based drug delivery and future developments. Nat Rev Gastroenterol Hepatol. 2022;19(4):219–238. doi: 10.1038/s41575-021-00539-w
   PubMed Web of Science ®Google Scholar
• Kirtane AR, Tang C, Freitas D, et al. Challenges and opportunities in the development of mucosal mRNA vaccines. Curr Opin Immunol. 2023;85:102388. doi: 10.1016/j.coi.2023.102388
   PubMed Web of Science ®Google Scholar
• Subramanian DA, Langer R, Traverso G. Mucus interaction to improve gastrointestinal retention and pharmacokinetics of orally administered nano-drug delivery systems. J Nanobiotechnology. 2022;20(1):362. doi: 10.1186/s12951-022-01539-x
   PubMed Web of Science ®Google Scholar
• Lyndra therapeutics [cited 2023 Nov 30] https://lyndra.com/
   Google Scholar
• Bellinger AM, Jafari M, Grant TM, et al. Oral, ultra-long-lasting drug delivery: Application toward malaria elimination goals. Sci Transl Med. 2016;8(865):365ra157. doi: 10.1126/scitranslmed.aag2374
   PubMedGoogle Scholar
• Hayward A, Bensel T, Mazdiyasni H, et al. Scalable gastric resident systems for veterinary application. Sci Rep. 2018;8(1):11816. doi: 10.1038/s41598-018-30212-3
   PubMedGoogle Scholar
• Kanasty R, Low S, Bhise N, et al. A pharmaceutical answer to nonadherence: once weekly oral memantine for Alzheimer’s disease. J Control Release. 2019;303:34–41. doi: 10.1016/j.jconrel.2019.03.022
   PubMed Web of Science ®Google Scholar
• Kirtane AR, Abouzid O, Minahan D, et al. Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy. Nat Commun. 2018;9(1):2. doi: 10.1038/s41467-017-02294-6
   PubMedGoogle Scholar
• Kirtane AR, Hua T, Hayward A, et al. A once-a-month oral contraceptive. Sci Transl Med. 2019;11(521):eaay2602. doi: 10.1126/scitranslmed.aay2602
   PubMed Web of Science ®Google Scholar
• Klausner EA, Lavy E, Friedman M, et al. Expandable gastroretentive dosage forms. J Control Release. 2003;90(2):143–162. doi: 10.1016/S0168-3659(03)00203-7
   PubMed Web of Science ®Google Scholar
• Pawar VK, Kansal S, Garg G, et al. Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems. Drug Deliv. 2011;18(2):97–110. doi: 10.3109/10717544.2010.520354
   PubMed Web of Science ®Google Scholar
• Pawar VK, Kansal S, Asthana S, et al. Industrial perspective of gastroretentive drug delivery systems: physicochemical, biopharmaceutical, technological and regulatory consideration. Expert Opin Drug Deliv. 2012;9(5):551–565. doi: 10.1517/17425247.2012.677431
   PubMed Web of Science ®Google Scholar
• Prinderre P, Sauzet C, Fuxen C. Advances in gastro retentive drug-delivery systems. Expert Opin Drug Deliv. 2011;8(9):1189–1203. doi: 10.1517/17425247.2011.592828
   PubMed Web of Science ®Google Scholar
• Chaudhari S, Walde S, Purohit A. A review on floating drug delivery systems. Int J Pharm Sci Res. 2023;81(1):37–41. doi: 10.47583/ijpsrr.2023.v81i01.008
   Google Scholar
• Mahmoud DB, Schulz-Siegmund M. Utilizing 4D printing to design smart gastroretentive, esophageal, and intravesical drug delivery systems. Adv Health Mat. 2022;12(19):2202631. doi: 10.1002/adhm.202202631
   Google Scholar
• Melocchi A, Uboldi M, Cerea M, et al. Shape memory materials and 4D printing in pharmaceutics. Adv Drug Deliv Rev. 2021a;173:216–237. doi: 10.1016/j.addr.2021.03.013
   PubMed Web of Science ®Google Scholar
• Verma M, Vishwanath K, Eweje F, et al. A gastric resident drug delivery system for prolonged gram-level dosing of tuberculosis treatment. Sci Transl Med. 2019;11(483):eaau6267. doi: 10.1126/scitranslmed.aau6267
   PubMed Web of Science ®Google Scholar
• Verma M, Chu JN, Salama JA, et al. Sa1527 development of a long-acting direct-acting antiviral system for Hepatitis C Virus treatment in a swine model. Gastroenterol. 2020;158(6):S–1321. doi: 10.1016/S0016-5085(20)33972-X
   Web of Science ®Google Scholar
• Inverardi N, Scalet G, Melocchi A, et al. Experimental and computational analysis of a pharmaceutical-grade shape memory polymer applied to the development of gastroretentive drug delivery systems. J Mech Behav Biomed Mater. 2021;124:104814. doi: 10.1016/j.jmbbm.2021.104814
   PubMed Web of Science ®Google Scholar
• Melocchi A, Inverardi N, Uboldi M, et al. Retentive device for intravesical drug delivery based on water-induced shape memory response of poly(vinil alcohol): design concept and 4D printing feasibility. Int J Pharm. 2019a;559:299–311. doi: 10.1016/j.ijpharm.2019.01.045
   PubMed Web of Science ®Google Scholar
• Melocchi A, Uboldi M, Inverardi N, et al. Expandable drug delivery system for gastric retention based on shape memory polymers: development via 4D printing and extrusion. Int J Pharm. 2019b;571:118700. doi: 10.1016/j.ijpharm.2019.118700
   PubMed Web of Science ®Google Scholar
• Uboldi M, Melocchi A, Moutaharrik S, et al. Dataset on a small-scale film-coating process developed for self-expanding 4D printed drug delivery devices. Coatings. 2021;11(10):1252. doi: 10.3390/coatings11101252
   Web of Science ®Google Scholar
• Uboldi M, Pasini C, Pandini S, et al. Expandable drug delivery systems based on shape memory polymers: impact of film coating on mechanical properties and release and recovery performance. Pharmaceutics. 2022;14(12):2814. doi: 10.3390/pharmaceutics14122814
   PubMed Web of Science ®Google Scholar
• Uboldi M, Perrotta C, Moscheni C, et al. Insights into the safety and versatility of 4D printed intravesical drug delivery systems. Pharmaceutics. 2023;15(3):757. doi: 10.3390/pharmaceutics15030757
   PubMed Web of Science ®Google Scholar
• Uboldi M, Gelain A, Buratti G, et al. Development of 4D printed intravesical drug delivery systems: scale-up of film-coating. J D Deliv Sci Technol. 2023;87:104875. doi: 10.1016/j.jddst.2023.104875
   Web of Science ®Google Scholar
• Hatipoglu BA. Rekindling hope for remission: current impact of diabetes for our world’s future health and economy. Endocrinol Metab Clin N Am. 2023;52(1):1–12. doi: 10.1016/j.ecl.2022.06.006
   PubMed Web of Science ®Google Scholar
• Baker C, Retzik-Stahr C, Singh V, et al. Should metformin remain the first-line therapy for treatment of type 2 diabetes? Ther Adv Endocrinol Metab. 2021;12:2042018820980225. doi: 10.1177/2042018820980225
   Web of Science ®Google Scholar
• Buse JB, DeFronzo RA, Rosenstock J, et al. The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies. Diabetes Care. 2016;39(2):198–205. doi: 10.2337/dc15-0488
   PubMed Web of Science ®Google Scholar
• Garber AJ, Duncan TG, Goodman AM, et al. Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial fn1. Am J Med. 1997;103(6):491–497. doi: 10.1016/S0002-9343(97)00254-4
   PubMed Web of Science ®Google Scholar
• Corcoran C, Jacobs TF. Metformin. Treasure Island (FL): StatPearls Publishing; 2023.
   Google Scholar
• Sanchez-Rangel E, Inzucchi SE. Metformin: clinical use in type 2 diabetes. Diabetologia. 2017;60(9):1586–1593. doi: 10.1007/s00125-017-4336-x
   PubMed Web of Science ®Google Scholar
• Sheehan MT. Current therapeutic options in type 2 diabetes mellitus: a practical approach. Clin Med Res. 2003;1(3):189–200. doi: 10.3121/cmr.1.3.189
   PubMedGoogle Scholar
• Boldhane SP, Kuchekar BS. Gastroretentive drug delivery of metformin hydrochloride: formulation and in vitro evaluation using 32 full factorial design. Current Drug Deliv. 2009;6(5):477–485. doi: 10.2174/156720109789941641
   PubMedGoogle Scholar
• Hoffman A, Stepensky D, Lavy E, et al. Pharmacokinetic and pharmacodynamic aspects of gastroretentive dosage forms. Int J Pharm. 2004;277(1–2):141–153. doi: 10.1016/j.ijpharm.2003.09.047
   PubMed Web of Science ®Google Scholar
• Kim JH, Song SH, Joo SH, et al. Formulation of a gastroretentive in situ oral gel containing metformin HCl based on DoE. Pharmaceutics. 2022;14(9):1777. doi: 10.3390/pharmaceutics14091777
   PubMed Web of Science ®Google Scholar
• Pawar R, Jagdale S, Randive D. Development of floating gastroretentive drug delivery system based on a novel excipient for metformin hydrochloride using mixture design. Int J Pharm Pharm Sci. 2020;12(10):62–71. doi: 10.22159/ijpps.2020v12i10.38678
   Google Scholar
• Kumar A, Sharma AK, Dutt R. A review of gastro-retentive drug delivery systems for antidiabetics and its present status. Res J Pharm Technol. 2021;14(1):538–546. doi: 10.5958/0974-360X.2021.00098.6
   Google Scholar
• Upadhyay P, Pandit JK, Upadhyay S, et al. Studies on formulation and optimization of gastro retentive multi-particulates of Glibenclamide and metformin hydrochloride for the treatment of type II diabetes mellitus using gelucire: a review. J Pharm Sci Res. 2010;2(6):351–354.
   Google Scholar
• Jeong YS, Jusko WJ. Meta-assessment of metformin absorption and disposition pharmacokinetics in nine species. Pharmaceuticals. 2021;14(6):545. doi: 10.3390/ph14060545
   Web of Science ®Google Scholar
• Scheen AJ. Clinical pharmacokinetics of metformin. Clin Pharmacokinet. 1996;30(5):359–371. doi: 10.2165/00003088-199630050-00003
   PubMed Web of Science ®Google Scholar
• Stepensky D, Friedman M, Srour W, et al. Preclinical evaluation of pharmacokinetic-pharmacodynamic rationale for oral CR metformin formulation. J Control Release. 2001;71(1):107–115. doi: 10.1016/S0168-3659(00)00374-6
   PubMed Web of Science ®Google Scholar
• Aroda VR, Ratner RE. Metformin and type 2 diabetes prevention. Diabetes Spectr. 2018;31(4):336–342. doi: 10.2337/ds18-0020
   PubMedGoogle Scholar
• Blough B, Moreland A, Mora A Jr. Metformin-induced lactic acidosis with emphasis on the anion gap. Proc (Bayl Univ Med Cent). 2015;28(1):31–33. doi: 10.1080/08998280.2015.11929178
   PubMedGoogle Scholar
• Nasri H, Rafieian-Kopaei M. Metformin: current knowledge. J Res Med Sci. 2014;19(7):658–664. doi: 10.12659/MSMBR.889344
   PubMed Web of Science ®Google Scholar
• Rojas LBA, Gomes MB. Metformin: an old but still the best treatment for type 2 diabetes. Diabetol Metab Syndr. 2013;5(1):6. doi: 10.1186/1758-5996-5-6
   PubMed Web of Science ®Google Scholar
• Hemels M, Jensen RCØ, Toumi M, et al. Relative effectiveness management of type II diabetes in europe: can the agencies’ demands be met? Value Health. 2010;13:A55. doi: 10.1016/S1098-3015(10)72253-1
   PubMed Web of Science ®Google Scholar
• Diabetes in Europe [cited 2023 Nov 30] https://www.mepinterestgroupdiabetes.eu/wp-content/uploads/2021/11/IDF-Atlas-Factsheet-2021_EUR.pdf
   Google Scholar
• IDF Diabetes Atlas [cited 2023 Nov 30] https://diabetesatlas.org/data/en/indicators/17/
   Google Scholar
• Jönsson B. Revealing the cost of type II diabetes in Europe. Diabetologia. 2002;45(7):S5–S12. doi: 10.1007/s00125-002-0858-x
   PubMed Web of Science ®Google Scholar
• Völzke H, Ittermann T, Schmidt CO, et al. Prevalence trends in lifestyle-related risk factors. Dtsch Arztebl Int. 2015;112(11):185–192. doi: 10.3238/arztebl.2015.0185
   PubMed Web of Science ®Google Scholar
• Zhuo X, Zhang P, Hoerger TJ. Lifetime direct medical costs of treating type 2 diabetes and diabetic complications. Am J Prev Med. 2013;45(3):253–261. doi: 10.1016/j.amepre.2013.04.017
   PubMed Web of Science ®Google Scholar
• Ferry JD. Viscoelastic properties of polymers. (NY) (NY): John Wiley & Sons; 1980.
   Google Scholar
• Daskalakis E, Hassan MH, Omar AM, et al. Accelerated degradation of poly-ε-caprolactone composite scaffolds for large bone defects. Polymers. 2023;15(3):670. doi: 10.3390/polym15030670
   PubMed Web of Science ®Google Scholar
• Lee SH, Lee JH, Cho YS. Analysis of degradation rate for dimensionless surface area of well-interconnected PCL scaffold via in-vitro accelerated degradation experiment. Tissue Eng Regen Med. 2014;11(6):446–452. doi: 10.1007/s13770-014-0067-y
   Web of Science ®Google Scholar
• Zhou ZX, Chen YR, Zhang JY, et al. Facile strategy on hydrophilic modification of poly(ε-caprolactone) scaffolds for assisting tissue-engineered meniscus constructs in vitro. Front Pharmacol. 2020;11:471. doi: 10.3389/fphar.2020.00471
   PubMed Web of Science ®Google Scholar
• Dumpa N, Butreddy A, Wang H, et al. 3D printing in personalized drug delivery: an overview of hot-melt extrusion-based fused deposition modeling. Int J Pharm. 2021;600:120501. doi: 10.1016/j.ijpharm.2021.120501
   PubMedGoogle Scholar
• Kallakunta VR, Sarabu S, Bandari S, et al. An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part I. Expert Opin Drug Deliv. 2019;16(5):539–550. doi: 10.1080/17425247.2019.1609448
   PubMed Web of Science ®Google Scholar
• Sarabu S, Bandari S, Kallakunta VR, et al. An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part II. Expert Opin Drug Deliv. 2019;16(6):567–582. doi: 10.1080/17425247.2019.1614912
   PubMed Web of Science ®Google Scholar
• Simões MF, Pinto RMA, Simões S. Hot-melt extrusion in the pharmaceutical industry: toward filing a new drug application. Drug Discov Today. 2019;24(9):1749–1768. doi: 10.1016/j.drudis.2019.05.013
   PubMed Web of Science ®Google Scholar
• Zema L, Loreti G, Melocchi A, et al. Injection molding and its application to drug delivery. J Control Release. 2012;159(3):324–331. doi: 10.1016/j.jconrel.2012.01.001
   PubMed Web of Science ®Google Scholar
• Dash TK, Konkimalla VB. Poly-є-caprolactone based formulations for drug delivery and tissue engineering: a review. J Control Release. 2012;158(1):15–33. doi: 10.1016/j.jconrel.2011.09.064
   PubMed Web of Science ®Google Scholar
• Elbjorn M, Provencio J, Phillips P, et al. An innovative polymeric platform for controlled and localized drug delivery. Pharmaceutics. 2023;15(7):1795. doi: 10.3390/pharmaceutics15071795
   PubMed Web of Science ®Google Scholar
• Henderson B. Polycaprolactones: properties, applications, and selected research. London (UK): Nova Science Publishers; 2017.
   Google Scholar
• Malikmammadov E, Tanir TE, Kiziltay A, et al. PCL and PCL-based materials in biomedical applications. J Biomater Sci Polym Ed. 2018;29(7–9):863–893. doi: 10.1080/09205063.2017.1394711
   PubMed Web of Science ®Google Scholar
• Mohamed R, Yusoh K. A review on the recent research of polycaprolactone (PCL). Adv Mat Res. 2015;1134:249–255. doi: 10.4028/www.scientific.net/AMR.1134.249
   Google Scholar
• Mondal D, Griffith MV, Venkatraman SS. Polycaprolactone-based biomaterials for tissue engineering and drug delivery: Current scenario and challenges. Int J Polym Mater. 2016;65(5):255–265. doi: 10.1080/00914037.2015.1103241
   Web of Science ®Google Scholar
• Faglie A, Emerine R, Chou S-F. Effects of poloxamers as excipients on the physicomechanical properties, cellular biocompatibility, and in vitro drug release of electrospun polycaprolactone (PCL. Fibers Polyms. 2023;15(14):2997. doi: 10.3390/polym15142997
   Google Scholar
• Douglas P, Jones AG, Walker D. Analysis of in vitro drug dissolution from PCL melt extrusion. Chem Eng J. 2010;164(2–3):359–370. doi: 10.1016/j.cej.2010.03.077
   Web of Science ®Google Scholar
• Guastaferro M, Baldino M, Cardea S, et al. Supercritical processing of PCL and PCL-PEG blends to produce improved PCL-based porous scaffolds. J Supercrit Fluids. 2022;186:105611. doi: 10.1016/j.supflu.2022.105611
   Web of Science ®Google Scholar
• Dalton M, Ebrahimi F, Xu H, et al. The influence of the molecular weight of poly(ethylene oxide) on the hydrolytic degradation and physical properties of polycaprolactone binary blends. Macromol. 2023;3(3):431–450. doi: 10.3390/macromol3030026
   Google Scholar
• Douglas P, Albadarin AB, Sajjia M, et al. Effect of poly ethylene glycol on the mechanical and thermal properties of bioactive poly(ε-caprolactone) melt extrudates for pharmaceutical applications. Int J Pharm. 2016;500(1–2):179–186. doi: 10.1016/j.ijpharm.2016.01.036
   PubMedGoogle Scholar
• Homaeigohar S, Boccaccini AR. Nature-derived and synthetic additives to poly(ɛ-caprolactone) nanofibrous systems for biomedicine; an updated overview. Front Chem. 2022;19:809676. doi: 10.3389/fchem.2021.809676
   Google Scholar
• Bezerra GSN, De Lima GG, Colbert DM, et al. Micro-injection moulding of PEO/PCL blend–based matrices for extended oral delivery of fenbendazole. Pharmaceutics. 2023;15(3):900. doi: 10.3390/pharmaceutics15030900
   PubMed Web of Science ®Google Scholar
• Bezerra GSN, de Lima TADM, Colbert DM, et al. Formulation and evaluation of fenbendazole extended-release extrudes processed by hot-melt extrusion. Polymers. 2022;14(19):4188. doi: 10.3390/polym14194188
   PubMed Web of Science ®Google Scholar
• Berger V, Green Buzhor M, Evstafeva D, et al. 3D printing of a controlled urea delivery device for the prevention of tooth decay. Int J Pharm. 2023;631:122528. doi: 10.1016/j.ijpharm.2022.122528
   PubMedGoogle Scholar
• Vlachou M, Siamidi A, Anagnostopoulou D, et al. Tuning the release of the pineal hormone melatonin via poly(ε-caprolactone)-based copolymers matrix tablets.J. Drug Deliv Sci Technol. 2023;79:04051. doi: 10.1016/j.jddst.2022.104051
   Web of Science ®Google Scholar
• Bartnikowski M, Dargaville TR, Ivanovski S, et al. Degradation mechanisms of polycaprolactone in the context of chemistry, geometry and environment. Prog Polym Sci. 2019;96:1–20. doi: 10.1016/j.progpolymsci.2019.05.004
   Web of Science ®Google Scholar
• Evonik Leading Beyond Chemistry [cited 2023 Nov 30]. https://healthcare.evonik.com/en/medical-devices/bioresorbable-polymers/standard-polymers
   Google Scholar
• Sun H, Mei L, Song C, et al. The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials. 2006;27(9):1735–1740. doi: 10.1016/j.biomaterials.2005.09.019
   PubMed Web of Science ®Google Scholar
• Balguri SP, Adelli GR, Tatke A, et al. Melt-cast noninvasive ocular inserts for posterior segment drug delivery. J Pharm Sci. 2017;106(12):3515–3523. doi: 10.1016/j.xphs.2017.07.017
   PubMed Web of Science ®Google Scholar
• Blackwell CJ, Haernvall K, Guebitz GM, et al. Enzymatic degradation of star poly(ε-caprolactone) with different central units. Polymers. 2018;10(11):1266. doi: 10.3390/polym10111266
   PubMed Web of Science ®Google Scholar
• Castilla-Cortázar I, Más-Estellés J, Meseguer-Dueñas JM, et al. Hydrolytic and enzymatic degradation of a poly(ε-caprolactone) network. Polym Degrad Stab. 2012;97(8):1241–1248. doi: 10.1016/j.polymdegradstab.2012.05.038
   Web of Science ®Google Scholar
• Gan Z, Liang Q, Zhang J, et al. Enzymatic degradation of poly(ε-caprolactone) film in phosphate buffer solution containing lipases. Polym Degrad Stab. 1997;56(2):209–213. doi: 10.1016/S0141-3910(96)00208-X
   Web of Science ®Google Scholar
• Pastorino L, Pioli F, Zilli M, et al. Lipase-catalyzed degradation of poly(ε-caprolactone). Enzyme Microb Technol. 2004;35(4):321–326. doi: 10.1016/j.enzmictec.2004.05.005
   Web of Science ®Google Scholar
• Liu M, Zhang T, Long L, et al. Efficient enzymatic degradation of poly (3-caprolactone) by an engineered bifunctional lipase-cutinase. Polym Degrad Stab. 2019;160:120–125. doi: 10.1016/j.polymdegradstab.2018.12.020
   Web of Science ®Google Scholar
• Woodruff MA, Hutmacher DW. The return of a forgotten polymer–polycaprolactone in the 21st century. Prog Polym Sci. 2010;35(10):1217–1256. doi: 10.1016/j.progpolymsci.2010.04.002
   Web of Science ®Google Scholar
• Chen DR, Bei JZ, Wang SG. Polycaprolactone microparticles and their biodegradation. Polym Degrad Stab. 2000;67(3):455–459. doi: 10.1016/S0141-3910(99)00145-7
   Web of Science ®Google Scholar
• Hoshino A, Isono Y. Degradation of aliphatic polyester films by commercially available lipases with special reference to rapid and complete degradation of poly(L-lactide) film by lipase PL derived from Alcaligenes sp. Biodegradation. 2002;13(2):141–147. doi: 10.1023/A:1020450326301
   PubMed Web of Science ®Google Scholar
• Cheng L, Lei L, Guo S. In vitro and in vivo evaluation of praziquantel loaded implants based on PEG/PCL blends. Int J Pharm. 2010;387(1–2):129–138. doi: 10.1016/j.ijpharm.2009.12.010
   PubMedGoogle Scholar
• Dalton M, Ebrahimi F, Xu H, et al. The influence of the molecular weight of poly(ethylene oxide) on the hydrolytic degradation and physical properties of polycaprolactone binary blends. Macromol. 2023;3(3):431–450. doi: 10.3390/macromol3030026
   Google Scholar
• Jiang Y, Mao K, Cai X, et al. Poly(ethyl glycol) assisting water sorption enhancement of poly(ε-caprolactone) blend for drug delivery. J Appl Polym Sci. 2011;122(4):2309–2316. doi: 10.1002/app.34382
   Web of Science ®Google Scholar
• Chang HI, Williamson MR, Perrie Y, et al. Precipitation casting of drug-loaded microporous PCL matrices: incorporation of progesterone by co-dissolution. J Control Release. 2005;106(3):263–272. doi: 10.1016/j.jconrel.2005.05.013
   PubMed Web of Science ®Google Scholar
• Asvadi NH, Dang NTT, Davis-Poynter N, et al. Evaluation of microporous polycaprolactone matrices for controlled delivery of antiviral microbicides to the female genital tract. J Mater Sci Mater Med. 2013;24(12):2719–2727.
   PubMed Web of Science ®Google Scholar
• Dang NTT, Turner MS, Coombes AGA. Development of intra-vaginal matrices from polycaprolactone for sustained release of antimicrobial agents. J Biomater Appl. 2013;28(1):74–83. doi: 10.1177/0885328212437393
   PubMed Web of Science ®Google Scholar
• Wong BS, Teoh SH, Kang L. Polycaprolactone scaffold as targeted drug delivery system and cell attachment scaffold for postsurgical care of limb salvage. Drug Deliv Transl Res. 2012;2(4):272–283. doi: 10.1007/s13346-012-0096-9
   PubMed Web of Science ®Google Scholar
• Chattopadhyay DK, Webster DC. Thermal stability and flame retardancy of polyurethanes. Prog Polym Sci. 2009;34(10):1068–1133. doi: 10.1016/j.progpolymsci.2009.06.002
   Web of Science ®Google Scholar
• Das A, Mahanwar P. A brief discussion on advances in polyurethane applications. Adv Ind Eng Polym Res. 2020;3(3):93–101. doi: 10.1016/j.aiepr.2020.07.002
   Google Scholar
• Petrović ZS, Ferguson J. Polyurethane elastomers. Prog Polym Sci. 1991;16(5):695–836. doi: 10.1016/0079-6700(91)90011-9
   Web of Science ®Google Scholar
• Xie F, Zhang T, Bryant P, et al. Degradation and stabilization of polyurethane elastomers. Progress Poly Sci. 2019;90:211–268. doi: 10.1016/j.progpolymsci.2018.12.003
   Web of Science ®Google Scholar
• Cherng JY, Hou TY, Shih MF, et al. Polyurethane-based drug delivery systems. Int J Pharm. 2013;450(1–2):145–162. doi: 10.1016/j.ijpharm.2013.04.063
   PubMed Web of Science ®Google Scholar
• Claeys B, Vervaeck A, Hillewaere XKD, et al. Thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding. Eur J Pharm Biopharm. 2015;90:44–52. doi: 10.1016/j.ejpb.2014.11.003
   PubMed Web of Science ®Google Scholar
• St John KR. The use of polyurethane materials in the surgery of the spine: a review. Spine J. 2014;14(12):3038–3047. doi: 10.1016/j.spinee.2014.08.012
   PubMed Web of Science ®Google Scholar
• Joseph J, Patel RM, Wenham A, et al. Biomedical applications of polyurethane materials and coatings. Trans Inst Met. 2018;96(3):121–129. doi: 10.1080/00202967.2018.1450209
   Google Scholar
• Koutsamanis I, Roblegg E, Spoerk M. Controlled delivery via hot-melt extrusion: a focus on non-biodegradable carriers for non-oral applications. J Drug Deliv Sci Technol. 2023;81:104289. doi: 10.1016/j.jddst.2023.104289
   Web of Science ®Google Scholar
• M’Bengue MS, Mesnard T, Chai F, et al. Evaluation of a medical grade thermoplastic polyurethane for the manufacture of an implantable medical device: the impact of FDM 3D-printing and gamma sterilization. Pharmaceutics. 2023;15(2):456. doi: 10.3390/pharmaceutics15020456
   PubMed Web of Science ®Google Scholar
• Verstraete G, Van Renterghem J, Van Bockstal PJ, et al. Hydrophilic thermoplastic polyurethanes for the manufacturing of highly dosed oral sustained release matrices via hot melt extrusion and injection molding. Int J Pharm. 2016;506(1–2):214–221. doi: 10.1016/j.ijpharm.2016.04.057
   PubMedGoogle Scholar
• Verstraete G, Samaro A, Grymonpré W, et al. 3D printing of high drug loaded dosage forms using thermoplastic polyurethanes. Int J Pharm. 2018;536(1):318–325. doi: 10.1016/j.ijpharm.2017.12.002
   PubMedGoogle Scholar
• Wendels S, Avérous L. Biobased polyurethanes for biomedical applications. Bioact Mater. 2021;6(4):1083–1106. doi: 10.1016/j.bioactmat.2020.10.002
   PubMed Web of Science ®Google Scholar
• Cailleaux S, Sanchez-Ballester NM, Gueche YA, et al. Fused deposition modeling (FDM), the new asset for the production of tailored medicines. J Control Release. 2021;330:821–841. doi: 10.1016/j.jconrel.2020.10.056
   PubMed Web of Science ®Google Scholar
• Melocchi A, Uboldi M, Briatico-Vangosa F, et al. The chronotopic™ system for pulsatile and colonic delivery of active molecules in the era of precision medicine: feasibility by 3D printing via fused deposition modeling (FDM). Pharmaceutics. 2021;13(5):759. doi: 10.3390/pharmaceutics13050759
   PubMed Web of Science ®Google Scholar
• Parulski C, Jennotte O, Lechanteur A, et al. Challenges of fused deposition modeling 3D printing in pharmaceutical applications: where are we now? Adv Drug Deliv Rev. 2021;175:13810. doi: 10.1016/j.addr.2021.05.020
   Web of Science ®Google Scholar
• Kong F, Singh RP. A human gastric simulator (HGS) to study food digestion in human stomach. J Food Sci. 2010;75(9):E627–35. doi: 10.1111/j.1750-3841.2010.01856.x
   PubMed Web of Science ®Google Scholar